Protein and Peptide Loaded Glyconanoparticle Formulation Service
Overview
Glyconanoparticles have been widely studied and applied in protein and peptide delivery systems due to their easy substitution of functional groups, their abundance in nature, and so on. Among them, polysaccharides such as chitosan, alginate, cellulose, and related derivatives have been most studied as nanoparticle materials. Especially in the field of cosmetics, skin permeability has been improved and skin health has been promoted by encapsulating various biofunctional molecules (e.g., growth factors) and delivering them to specific sites. A good delivery system is needed to ensure a high embedding rate and good release ability. CD BioGlyco focuses on the cosmetic field and provides a one-stop service for protein and peptide-loaded glyconanoparticle formulation. We optimize the glyconanoparticle to ensure good release ability and a high embedding rate.
Advanced Glyconanoparticle and Customized Solutions
Our professional staff develops appropriate customized solutions and combines them with our comprehensive quality management system to deliver products that exceed client expectations. Based on our well-established GlycoNano™ Platform, specific services include the following:
Glyconanoparticle Design
Base materials such as chitosan and alginate are used to prepare glyconanoparticles. We select appropriate monomers, cross-linking agents, etc., and prepare them using appropriate methods to ensure high stability and encapsulation rates.
Development of Glyconanoparticle
We optimize the formulation and synthesis process of glyconanoparticle to ensure the quality and good performance of the product. In addition to glyconanoparticles, glycol nanohydrogel has good applications in the delivery of active substances. We also prepare Glycol Nanohydrogel by Precipitation Polymerization, Inverse Emulsion Polymerization, etc., and analyze its application in the delivery of active substances such as proteins and peptides.
Characterization of Glyconanoparticles
In the field of cosmetics, the properties of glyconanoparticles are closely related to many parameters, such as size, shape, and surface functionalization. Therefore, after the development of glyconanoparticles, we perform characterization services to assess the Physicochemical Properties and Interactions. The detailed characterization includes the following:
- Particle size analysis
- Zeta potential measurements
- X-ray photoelectron spectroscopy (XPS)
- Scanning electron fibrillation
- Transmission electron microscopy (TEM)
- Differential scanning calorimetry (DSC)
- Cryo-etching electron microscopy
- Affinity analysis
- Other analyses
Preclinical Studies of Glyconanoparticles
Combining the extensive experience and knowledge base in Glyconanoparticle Formulation, we evaluate the stability, function, deliverability, and safety of glyconanoparticles under simulated physiological conditions. Specific characterizations include the following:
- Loading efficiency studies: Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), etc., are used to detect the amount of protein or peptide successfully loaded.
- Release kinetics: Release profiles are studied under various conditions.
- Stability testing: Stability is analyzed to ensure stability under storage conditions.
- Biological Characterization: This process includes cytotoxicity analysis, immune response assessment, etc.
- Functional analysis: We analyze the regenerative effect on the skin, moisturizing effect, etc., of glyconanoparticles loaded with proteins or peptides.
Our services apply to a wide range of proteins and peptides, including but not limited to the following:
- Collagen
- Oligopeptide
- Polypeptide
- Silk protein
- Keratin
Workflow
We understand our clients' experimental needs in detail and develop functional biomaterials with good biocompatibility for use in the cosmetic field.

Applications
- Skincare actives: We develop glyconanoparticles that deliver active ingredients such as proteins and peptides in a targeted manner to promote skin health.
- Anti-aging compounds: We develop glyconanoparticles that effectively deliver hyaluronic acid and other substances to enhance skin permeability and improve skin care effects.
- Other types of cosmetics: Our glyconanoparticles are also suitable for the encapsulation of other active substances to broaden their application in cosmetics.
Advantages
- Our highly skilled scientists and laboratory teams have extensive experience in glyconanoparticle development to ensure that our products meet the needs of our clients' real-world applications.
- A comprehensive range of advanced analytical tools characterize glyconanoparticles to ensure accurate and efficient analysis.
- We offer a customized service to meet the specific requirements of each client, ensuring alignment with their goals and research objectives.
Publication Data
Technology: Salting-out method, SEM
Journal: International Journal of Biological Macromolecules
IF: 5.162
Published: 2023
Results: In this study, the researchers developed a nanoparticle that can be used as a stable delivery system, in which the use of carboxymethyl levan significantly increased the protein encapsulation rate. Characterization of the nanoparticles showed zeta potential and size of -19.1 mV and 199.9 ± 3.87 nm, respectively, and promising applications in skin regeneration and moisturization, among others. Human epidermal growth factor was loaded using the nanoparticles and the results showed that its activity was maintained over 100%. The analytical results indicate that the nanoparticles loaded with human epidermal growth factor can be used for cosmetic applications with high functionality, stability, and capture ability.
Fig.1 Morphological observation of nanoparticles loaded with human epidermal growth factor. (Ko, et al., 2023)
Frequently Asked Questions
- What are the benefits of using glyconanoparticles to deliver proteins and peptides?
- Improved stability: Glyconanoparticles are used to improve the stability of active ingredients such as proteins and peptides and reduce their degradation.
- Controlled slow release: In addition to encapsulating active ingredients such as proteins and peptides, glyconanoparticles are able to control their slow release, making them more effective, such as in moisturizing effects.
- Improved solubility and safety: Glyconanoparticles are used to improve the solubility and safety of active ingredients such as proteins and peptides.
- Do you offer customized services?
Of course, we offer customization services for protein and peptide-loaded glyconanoparticle formulations to meet the specific needs of our clients. This includes suitable glyconanoparticle design, optimization for better embedding rates, and good release profiles.
CD BioGlyco has industry-leading development and analytical capabilities and offers customized protein and peptide-loaded glyconanoparticle formulation services. Please feel free to contact us with details of your project, including the type of protein or peptide, glyconanoparticle detail requirements, and any specific goals you may be facing. Our team will provide a customized solution.
Reference
- Ko, H.; et al. Dual-functional carboxymethyl levan-based protein carrier for cosmeceutical application of human epidermal growth factor. International Journal of Biological Macromolecules. 2023, 229: 181-187.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




